DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019647
NDA 019647 describes POTASSIUM CITRATE, which is a drug marketed by Ut Sw Medctr, Mountain, Strides Pharma, Teva Pharms Usa Inc, and Zydus Pharms Usa Inc, and is included in five NDAs. It is available from four suppliers. Additional details are available on the POTASSIUM CITRATE profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and thirty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and thirty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 019647
| Tradename: | POTASSIUM CITRATE |
| Applicant: | Ut Sw Medctr |
| Ingredient: | potassium citrate |
| Patents: | 0 |
| Therapeutic Class: | Therapeutic Nutrients/Minerals/Electrolytes |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019647
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
| Approval Date: | Oct 13, 1988 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
| Approval Date: | Oct 13, 1988 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
